FDA recently removes the black box warnings on menopausal hormone therapy after 20 years

CHARLOTTE, NC- As of last month, according to the US Department of Health and Human Services, the FDA is requesting that companies remove references to health risks with use like: risk of cardiovascular disease, breast cancer and probable dementia for Hormone Replacement Therapies (HRT).

founder of the BHRT Training Academy, and author of , “The Hormone Makeover, “ Donna White, stopped by Rising Studios to discuss the impact of the decision.